Cerevel Therapeutics Holdings, Inc.
CERE · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $6,871,174 | $4,770,918 | $4,427,811 | $1,959,437 |
| - Cash | $990,965 | $136,521 | $193,018 | $383,623 |
| + Debt | $480,778 | $366,672 | $36,547 | $33,005 |
| Enterprise Value | $6,360,987 | $5,001,069 | $4,271,340 | $1,608,819 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$5,627 | -$4,903 | -$2,731 | -$397 |
| % Margin | – | – | – | – |
| EBITDA | -$416,145 | -$336,829 | -$211,984 | -$148,719 |
| % Margin | – | – | – | – |
| Net Income | -$432,842 | -$351,511 | -$222,446 | -$152,142 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.67 | -2.32 | -1.63 | -1.29 |
| % Growth | -15.1% | -42.3% | -26.4% | – |
| Operating Cash Flow | -$342,301 | -$293,187 | -$178,546 | -$117,802 |
| Capital Expenditures | -$3,808 | -$3,954 | -$10,503 | -$18,892 |
| Free Cash Flow | -$346,109 | -$297,141 | -$189,049 | -$136,694 |